Increasing Prevalence of Chronic Respiratory Conditions will trigger the growth rate of Asthma Spacers Market During 2022-2028

According to our new research study on "Asthma Spacers Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Product and Distribution Channel," the market is expected to grow from US$ 1,666.48 million in 2022 to US$ 2,266.47 million by 2028; it is estimated to grow at a CAGR of 5.3% from 2022 to 2028. Rising investments by public and private organizations in R&D activities for product innovation are driving the global asthma spacers market. However, rising costs of these devices and lack of awareness among people about the product are the factors restraining the market growth.

Asthma causes swellings in airways passages, resulting in the narrowing of airways to the lungs and further causing trouble in breathing, tightness in the chest, wheezing, and other associated indications. Chronic obstructive pulmonary disease (COPD) also causes obstructions in airflow. The causes of these conditions are unclear; however, genetic factors, environmental conditions, overweight conditions, and smoking are major risk factors. Most of the time, it is very difficult to distinguish asthma from COPD in elderly patients due to similar clinical features, while reoccurrence of asthma is a major problem in younger patients. The majority of the patients with asthma can be treated successfully in primary care, while few cases require specialist referral and supervision. Respiratory conditions are commonly observed across the US, and the prevalence of certain conditions, such as asthma, COPD, chronic bronchitis, and emphysema, is continually increasing in the country.

A higher asthma epidemic represents the possibility of increased adoption of inhalers, which eventually drive the US asthma spacers market. For instance, according to a study published by the Asthma and Allergy Foundation of America, 1 in 13 people suffers from asthma in the US. Furthermore, according to the National Health Interview Survey, 2018, an estimated 13.6% of the population suffers from asthma in the country. Besides, according to World Health Organization (WHO), asthma affected around 262 million people and caused approximately 461,000 deaths in 2019.

Moreover, the cases of asthma in Europe are also increasing constantly, and more than 30 million children and adults under 45 years of age are currently living with asthma in Europe, as per the data of the European Lung White Book. Among all the European countries, the UK, Spain, and Ireland have some of the highest asthma rates. According to Asthma UK, in 2017, there were 77,124 hospital admissions for asthma, and every 10 seconds, someone had a potentially life-threatening asthma attack in the UK. For instance, according to the Centers for Disease Control and Prevention (CDC), around 25 million Americans had asthma in 2019, and 3,524 died among them, which is the most common chronic condition among American children, where one child out of every 12 has asthma.

Government authorities and healthcare institutions are implementing various programs to increase asthma awareness to prevent morbidity due to the disease. The National Asthma Control Program (NACP), launched by the Centers for Disease Control and Prevention, is working continually to increase awareness regarding asthma and curb the disease. The program is dedicated to conducting asthma surveillance and research to deal with the disease. Such programs are boosting the adoption of inhalers, which are, in turn, driving market growth.

Cipla Inc., PARI GmbH, Koninklijke Philips N.V., Lupin, HAAG-STREIT GROUP, Laboratoire ProtecSom, Monaghan Medical Corporation, Koo Medical Equipment, Agaplastic, Metal Zug, and Teleflex Incorporated are among the key companies operating in the asthma spacers market.

The report segments the Asthma Spacers market as follows:

The asthma spacers market is segmented intoproduct, distribution channel, and geography. Based on product, the market is segmented into aerochamber, optichmaber, volumatic, and inspirease. Based on distribution channel, the asthma spacers market is segmented into retail pharmacy, hospital pharmacy, and ecommerce. Based on geography, the asthma spacers market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, Africa, and the Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com